EUVIMEDEUVIMED entdecken
Crossref

Cisplatin-induced primary ovarian insufficiency-related injury in mice is mediated through defects in cholesterol synthesis and subsequent activation of p53 signaling

Ruixin Zhang, Fei Wang, Jiaoyu Li, Huirong Li, Nie Zhang, Hongxu Chen, Xiaoying Liu, Xuqing Li, Zhaolian Wei, Fei Zhong, Fengyu Zhu

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Ruixin Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, The First Affiliated Hospital of Anh…. Hauptthemen laut MEDLINE: Cisplatin, Tumor Suppressor Protein p53, Cholesterol, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Anhui Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism by which chemotherapy induces primary ovarian insufficiency (POI) remains unclear. This study aims to investigate the role of HMGCR in cisplatin-induced ovarian toxicity and its downstream molecular pathways. We established a cisplatin-induced POI mouse model. The protein levels were validated by immunohistochemistry (IHC), immunofluorescence (IF) and western blot (WB). Granulosa cell line KGN were used for in vitro experiments. RNA sequencing (RNA-seq) analyzed gene expression changes in mouse ovaries and KGN cells after HMGCR inhibition. Rescue experiments used exogenous cholesterol, and p53 agonist Nutlin-3a and inhibitor Pifithrin-α (PFT-α) for functional validation. Transcriptome analysis revealed that the cholesterol synthesis pathway was significantly suppressed in the ovaries of POI mice, with HMGCR-the rate-limiting enzyme in cholesterol biosynthesis-being markedly downregulated. Inhibition or knockdown of HMGCR in KGN cells led to increased ROS accumulation, elevated levels of lipid peroxidation (LPO), and enhanced apoptosis. Exogenous supplementation of cholesterol effectively mitigated these effects, confirming that cholesterol deficiency is the causative factor. Furthermore, RNA-seq analysis demonstrated that HMGCR suppression significantly activated the p53 signaling pathway, as evidenced by increased p53 phosphorylation, acetylation (K382), and upregulation of downstream pro-apoptotic targets p21 and PUMA. Pharmacological inhibition of p53 with PFT-α attenuated HMGCR inhibition-induced oxidative damage and apoptosis. In conclusion, cisplatin-induced ovarian injury is mediated through defects in cholesterol synthesis and subsequent p53 activation, identifying the HMGCR-cholesterol-p53 axis as a potential therapeutic target for POI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinTumor Suppressor Protein p53CholesterolSignal TransductionPrimary Ovarian InsufficiencyAnimalsFemaleMiceApoptosisCell LineMice, Inbred C57BLGranulosa CellsReactive Oxygen Species

Stichwörter der Autor:innen

Cholesterol synthesisCisplatinHMGCROxidative stressp53 signaling pathway

Substanzen

CisplatinTumor Suppressor Protein p53CholesterolTrp53 protein, mouseReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei 230022, Anhui, China; D…
  • Department of Obstetrics and Gynecology, NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei 230022, Anhui, China; E…

Förderung

  • Anhui Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, R., Wang, F., Li, J., Li, H., Zhang, N., Chen, H., Liu, X., Li, X., Wei, Z., Zhong, F., & Zhu, F. (2026). Cisplatin-induced primary ovarian insufficiency-related injury in mice is mediated through defects in cholesterol synthesis and subsequent activation of p53 signaling. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112665

Vancouver

Zhang R, Wang F, Li J, Li H, Zhang N, Chen H, et al. Cisplatin-induced primary ovarian insufficiency-related injury in mice is mediated through defects in cholesterol synthesis and subsequent activation of p53 signaling. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112665

BibTeX
@article{Zhang2026,
  author = {Zhang, Ruixin and Wang, Fei and Li, Jiaoyu and Li, Huirong and Zhang, Nie and Chen, Hongxu and Liu, Xiaoying and Li, Xuqing and Wei, Zhaolian and Zhong, Fei and Zhu, Fengyu},
  title = {Cisplatin-induced primary ovarian insufficiency-related injury in mice is mediated through defects in cholesterol synthesis and subsequent activation of p53 signaling},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112665}
}
Kostenlos starten →